Oncologic indications and contra-indications of the hotmonal use in menopause
The lile expectation has been changeable the manner of menopause handling.At the saine time,the women after fifty have the highest incidence of cancer. The hormonal replacement therapy (HT) tu date have very few indication for patients with cancer. The oncologic contrai...
Guardado en:
Autor principal: | |
---|---|
Formato: | Artículo revista |
Lenguaje: | Español |
Publicado: |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2021
|
Materias: | |
Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/27917 |
Aporte de: |
id |
I10-R10article-27917 |
---|---|
record_format |
ojs |
institution |
Universidad Nacional de Córdoba |
institution_str |
I-10 |
repository_str |
R-10 |
container_title_str |
Revistas de la UNC |
language |
Español |
format |
Artículo revista |
topic |
. |
spellingShingle |
. Sarriá, José Antonio Oncologic indications and contra-indications of the hotmonal use in menopause |
topic_facet |
. |
author |
Sarriá, José Antonio |
author_facet |
Sarriá, José Antonio |
author_sort |
Sarriá, José Antonio |
title |
Oncologic indications and contra-indications of the hotmonal use in menopause |
title_short |
Oncologic indications and contra-indications of the hotmonal use in menopause |
title_full |
Oncologic indications and contra-indications of the hotmonal use in menopause |
title_fullStr |
Oncologic indications and contra-indications of the hotmonal use in menopause |
title_full_unstemmed |
Oncologic indications and contra-indications of the hotmonal use in menopause |
title_sort |
oncologic indications and contra-indications of the hotmonal use in menopause |
description |
The lile expectation has been changeable the manner of menopause handling.At the saine time,the women after fifty have the highest incidence of cancer. The hormonal replacement therapy (HT) tu date have very few indication for patients with cancer. The oncologic contraindication for 1-IT are analysed in detail,particulary for breast tumor. At the present tirne,the studies and the metanalysis oii HT and hreat cancer ilot showed a quantitative increase on the risk. We are looking for selective hormone with antagonist for enclornetrium and breast receptors, and effectiveness oil the others areas. |
publisher |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología |
publishDate |
2021 |
url |
https://revistas.unc.edu.ar/index.php/med/article/view/27917 |
work_keys_str_mv |
AT sarriajoseantonio oncologicindicationsandcontraindicationsofthehotmonaluseinmenopause AT sarriajoseantonio indicacionesycontraindicacionesoncologicasdelusodehormonasenlamenopausia |
bdutipo_str |
Revistas |
_version_ |
1764819782191808516 |